Sorin launches neurostim heart failure trial, shares dip on Q4 prelims

Sorin launches a study of a neurostimulation implant for heart failure and watches its shares slide after revealing preliminary 4th-quarter and 2014 results.

Sorin Group

News Well, Clinical Trials, MassDevice.com Earnings Roundup, 2014, Neuromodulation/Neurostimulation, Q4

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DGsJOT